A Randomized,Double-Blind Trial of Palonosetron Compared with Ondansetron in Preventing Postoperative Nausea and Vomiting after Gynaecological Laparoscopic Surgery

Abstract

This randomized, double-blind study evaluated the relative efficacy of palonosetron (a new, selective 5-hydroxytryptamine type 3 [5-HT₃] receptor antagonist) and ondansetron in preventing postoperative nausea and vomiting (PONV) in patients undergoing gynaecological laparoscopic surgery. Patients received either palonosetron 0.075 mg (n = 45) or ondansetron 8 mg (n = 45), intravenously, immediately before induction of general anaesthesia. The occurrence of nausea and vomiting and the severity of nausea according to a visual analogue scale were monitored immediately after the end of surgery and during the following 24 h. The incidence of PONV was significantly lower in the palonosetron group compared with the ondansetron group (42.2% vs 66.7%, respectively). There were no significant statistical differences in the visual analogue scale for nausea. In conclusion, palonosetron 0.075 mg was more effective than ondansetron 8 mg in preventing PONV.

Keywords

Palonosetron Ondansetron Postoperative nausea and vomiting (PONV)Gynaecological laparoscopic surgery

References

Watcha

White

: Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77: 162–184.

Muchatuta

Paech

: Management of postoperative nausea and vomiting: focus on palonosetron. Ther Clin Risk Manag 2009; 5: 21–34.

Gan

: Risk factors for postoperative nausea and vomiting. Anesth Analg 2006; 102: 1884–1898.

Apfel

Läärä

Koivuranta

: A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91: 693–700.

Wong

Clark

Leung

: The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro. Br J Pharmacol 1995; 114: 851–859.

Stoltz

Cyong

Shah

: Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese healthy subjects. J Clin Pharmacol 2004; 44: 520–531.

Kovac

Eberhart

Kotarski

: A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72hour period. Anesth Analg 2008; 107: 439–444.

Aapro

Grunberg

Manikhas

: A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy. Ann Oncol 2006; 17: 1441–1449.

Sweitzer

: Overview of preoperative assessment and management. In: Anesthesiology ( Longnecker

, ed.). Columbus: McGraw-Hill, 2008; pp 42–43.

10.

Yun

Kim

: Comparison of azasetron and ondansetron for preventing postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery. Yonsei Med J 2010; 51: 88–92.

11.

Gupta

Elkassabany

: Does the routine prophylactic use of antiemetics affect the incidence of postdischarge nausea and vomiting following ambulatory surgery?: A systematic review of randomized controlled trials. Anesthesiology 2003; 99: 488–495.

12.

Habib

Gan

: Evidence-based management of postoperative nausea and vomiting: A review. Can J Anesth 2004; 51: 326–341.

13.

Paventi

Santevecchi

Ranieri

: Efficacy of a single-dose ondansetron for preventing postoperative nausea and vomiting after laparoscopic cholecystectomy with sevoflurane and remifentanil infusion anaesthesia. Eur Rev Med Pharmacol Sci 2001; 5: 59–63.

14.

Gralla

Lichinitser

Van Der Vegt

: Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann Oncol 2003; 14: 1570–1577.

15.

Kovac

: Prevention and treatment of postoperative nausea and vomiting. Drugs 2000; 59: 213–243.

16.

Koivuranta

Ala-Kokko

Jokela

: Comparison of ondansetron and tropisetron combined with droperidol for the prevention of emesis in women with a history of postoperative nausea and vomiting. Eur J Anaesthesiol 1999; 16: 390–395.

17.

Sinclair

Chung

Mezei

: Can postoperative nausea and vomiting be predicted? Anesthesiology 1999; 91: 109–118.

18.

Newberry

Watkins

Sprosen

: BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors. Neuropharmacology 1993; 32: 729–735.

19.

Tramer

Reynolds

Moore

: Efficacy, dose—response, and safety of ondansetron in prevention of postoperative nausea and vomiting: A quantitative systematic review of randomized placebo-controlled trials. Anesthesiology 1997; 87: 1277–1289.

20.

Gan

: Mechanisms underlying postoperative nausea and vomiting and neurotransmitter receptor antagonist-based pharmacotherapy. CNS Drugs 2007; 21: 813–833.

21.

Kovac

: Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists. J Clin Anesth 2006; 18: 304–318.

22.

Apfel

Kranke

Eberhart

: Comparison of predictive models for postoperative nausea and vomiting. Br J Anaesth 2000; 88: 234–240.

23.

Scuderi

James

Harris

: Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy. Anesth Analg 2000; 91: 1408–1414.

24.

Paech

Lee

Evans

: The effect of anaesthetic technique on postoperative nausea and vomiting after day-case gynaecological laparoscopy. Anaesth Intensive Care 2002; 30: 153–159.

25.

Gan

Coop

Philip

: A randomized, double-blind study of granisetron plus dexamethasone versus ondansetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing abdominal hysterectomy. Anesth Analg 2005; 101: 1323–1329.

26.

Fujii

Saitoh

Tanaka

: Prophylactic antiemetic therapy with granisetron—droperidol combination in patients undergoing laparoscopic cholecystectomy. Can J Anaesth 1998; 45: 541–544.

27.

Elhakim

Nafie

Mahmoud

: Dexamethasone 8 mg in combination with ondansetron 4 mg appears to be the optimal dose for the prevention of nausea and vomiting after laparoscopic cholecystectomy. Can J Anaesth 2002; 49: 922–926.

28.

Candiotti

Kovac

Melson

: A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting. Anesth Analg 2008; 107: 445–451.

29.

Stoltz

Parisi

Shah

: Pharmacokinetics, metabolism and excretion of intravenous [¹⁴C]-palonosetron in healthy human volunteers. Biopharm Drug Dispos 2004; 25: 329–337.

30.

Leslie

Gan

: Meta-analysis of the safety of 5-HT₃ antagonists with dexamethasone or droperidol for prevention of PONV. Ann Pharmacother 2006; 40: 856–872.

31.

Gan

: Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting. Curr Opin Anaesthesiol 2006; 19: 606–611.

32.

Navari

: Palonosetron: A second generation 5-hydroxytryptamine 3 receptor antagonist. Expert Opin Drug Metab Toxicol 2009; 12: 1577–1586.